The Prequalification of Medicines Programme (PQP) • A United Nations Programme managed by WHO • Started in March 2001 as a Pilot Project: Focus on HIV/AIDS • Partners included WHO, UNICEF, UNFPA, UNAIDS and supported by World Bank • Quickly expanded to include Tuberculosis, Malaria, Reproductive Health, Influenza and ...

PEPFAR’s Evolution. From Emergency Response to Sustainable Impact for an AIDS-free Generation. 2003-2007: PEPFAR 1 Emergency Response Delivering prevention, care and treatment services Building and strengthening health systems to deliver HIV services 2008-2012: PEPFAR 2 Shift to sustainable response Shared responsibility and country driven programs Scaling up core interventions (ART, PMTCT, and VMMC) ...

Purpose of the new PQ financing strategy: • Maintain the overall objective of PQ to provide assured safe, efficacious and quality drugs, vaccines, diagnostics and devices while increasing supply and access; • Need for an innovative, practical and sustainable funding approach for the WHO PQ programme; • Reduce ...

Согласно докладу ЮНЭЙДС о глобальной эпидемии СПИДа 2013 г., Восточная Европа и Центральная Азия (ВЕЦА) является регионом, где продолжается распространение эпидемии ВИЧ, причем самое большое бремя приходится на Россию и Украину. В течение последних десяти лет страны региона ВЕЦА достигли значительного прогресса в осуществлении мер ...

В рамках этого исследования проанализированы з точки зрения доступности лекарств некоторые проблемы и пути их решения, связанные с реализацией Соглашения ТРИПС в Беларуси, Грузии, Молдове и Украине. Прежде всего, в данном отчёте рассматриваются основные международные обязательства государств, связанные с обеспечением доступа к основным и/или жизненноважным ...

Synthesizes findings on the dual challenges of women drug users: greater vulnerability to sexually and injection-transmitted HIV infection and less access to services than men. Makes recommendations on outreach, testing, treatment, care, and policy.

The paper provides information on the prices paid by 20 middle-income countries for adult and paediatric formulations of antiretroviral (ARV) drugs recommended by the World Health Organization (WHO). It links this information with an analysis of the intellectual property situation of the selected ARV medicines ...

How do intellectual property rights affect access to HIV medicines and other health technologies? This document provides a review of key issues related to intellectual property policies and their potential impact on access to HIV and other medicines. It is intended as an introduction to the ...

This paper forms part of Phase 2 of a project undertaken by the World Health Organization and supported by the European Commission on improving access to medical products in developing countries through building capacity for local production and related technology transfer. Phase 1 of the project ...

The purpose of this working paper is to revise and update the antiretroviral (ARV) priorities of the Medicines Patent Pool (MPP) taking into consideration recent developments in the clinical, market and intellectual property landscape for different ARVs. As part of its mandate, MPP assigns greater ...

These papers were written to inform the work of the Global Commission on HIV and the Law, which is convened by UNDP on behalf of UNAIDS. The content, analysis, opinions and recommendations in the papers do not necessarily reflect the views of the Commission, UNDP or ...